French Childhood Cancer Survivor Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorInstitut National de la Santé Et de la Recherche Médicale, France

About this trial

The FCCSS is a multicentric national large-scale collaborative population-based study of children treated for a solid tumor before 2000 in France and before the age of 19 years.

The study is concerned by improving knowledge about the long-term effects caused by cancer and its treatments including adverse health and social outcomes.

The main reason of the FCCSS is to estimate the risk of adverse health and social outcomes that may occur after a cancer treatment and to prevent them by providing adapted follow-up care.

The cohort will be followed for up to 20 years from 2011.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All types of solid childhood cancer in France

Age at diagnosis: Below age 19

Period of diagnosis: between 1st January 1942 and 31st December 1999

Complete identification (first name, last name, date of birth and place of birth)

Disqualifiers

Leukaemia cases

Trial population

The study population includes all types of solid childhood cancer cases (with the exception of leukemia) treated in, or before the end of, 1999. The study population is based on the French clinical trials, registries, cohorts and department of paediatric oncology.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

18,000 Participants
are grouped into 3 trial groups
Group A: Treatment cohort (chemo/radiotherapy)
Group B: Self-questionnaire cohort
Group C: Medical Insurance cohort

Trial outcomes

Primary outcomes

1

All health events of interest

* all causes mortality (e.g. cerebrovascular, cardiovascular,...) * all iatrogenic events (e.g. diabetes, thyroid adenomas, cardiac diseases, second malignant solid tumors, secondary leukemia,...)

Time frame
by time since diagnosis of solid childhood cancer

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Institut National de la Santé Et de la Recherche Médicale, France

Lead sponsor

Ligue contre le cancer, France

Collaborator

National Research Agency, France

Collaborator

Programme hospitalier de recherche clinique, France

Collaborator